Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three‐arm study

BACKGROUND AND AIMS: In 2015, Georgia began a hepatitis C virus (HCV) elimination programme. Although screening programmes have been decentralized for high‐risk groups, viraemic testing remains a bottleneck for people who inject drugs. Here, we describe two models of viraemic testing that aimed to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shilton, Sonjelle, Markby, Jessica, Japaridze, Maia, Chihota, Violet, Shadaker, Shaun, Gvinjilia, Lia, Tsereteli, Maia, Alkhazashvili, Maia, Butsashvili, Maia, Stvilia, Ketevan, Ruiz, Ryan Jose, Asatiani, Alexander, Adamia, Ekaterine, Easterbrook, Philippa, Khonelidze, Irma, Gamkrelidze, Amiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Viral Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306782/
https://www.ncbi.nlm.nih.gov/pubmed/35129278
http://dx.doi.org/10.1111/liv.15191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306782/
https://www.ncbi.nlm.nih.gov/pubmed/35129278
http://dx.doi.org/10.1111/liv.15191

Ejemplares similares